Add Company
Join Now

Dunad Therapeutics Revenue and Competitors

License our Company Data API

Cambridge, Cambridge

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Dunad Therapeutics's estimated annual revenue is currently $2.7M per year.(i)
  • Dunad Therapeutics's estimated revenue per employee is $77,500

Employee Data

  • Dunad Therapeutics has 35 Employees.(i)
  • Dunad Therapeutics grew their employee count by 46% last year.

Dunad Therapeutics's People

NameTitleEmail/Phone
1
Founder, acting CEO, CSOReveal Email/Phone
2
Chief Scientific OfficerReveal Email/Phone
3
SVP Drug DiscoveryReveal Email/Phone
4
Head Finance and OperationsReveal Email/Phone
5
Director Medicinal ChemistryReveal Email/Phone
6
Director Computational SciencesReveal Email/Phone
7
Chief Financial OfficerReveal Email/Phone
8
Senior Data ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.8M1344%$10MN/A
#2
$2.7M3546%N/AN/A
#3
$0.9M1318%$8.48MN/A
#4
$0.8M1011%N/AN/A
#5
$3.6M4413%$16MN/A
#6
$2.4M3119%$11.3MN/A
#7
$2.9M3513%$16MN/A
#8
$2.6M294%$13.9MN/A
Add Company

What Is Dunad Therapeutics?

Dunad Therapeutics is a biopharmaceutical company focusing on the development of next-generation targeted oral protein degradation therapies. Dunad’s platform enables selective degradation via direct target modification using tunable mono-valent small molecules, allowing for the development of more drug-like, orally bioavailable and CNS-accessible protein degraders.

keywords:N/A

N/A

Total Funding

35

Number of Employees

$2.7M

Revenue (est)

46%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A35-5%N/A
#2
$6.7M3530%N/A
#3
$2.7M35-58%$65M
#4
$3.6M3535%$26M
#5
$3.5M3521%N/A